Therefore, this study aims to explore the association between the FOXP3 rs2232368 polymorphism and HT susceptibility in an Iraqi cohort, with the goal of identifying population-specific genetic risk factors and potentially discovering novel therapeutic targets. This evidence concerns the gene FOXP3 and hematocrit.